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INTRODUCTION 
This study aims to correlate the relationship between metabolic syndrome and 
ischemic stroke based on its severity and morbidity after a period of 60 days. 
   Metabolic syndrome is in itself an independent risk factor for 
the development of stroke, coronary artery disease, peripheral vascular diseases, 
carotid plaques and so on. There are studies that correlate risk of development 
of ischemic stroke and metabolic syndrome and recently a study showed that 
there was no significant correlation between metabolic syndrome and ischemic 
stroke. 
   Stroke as we all know is one of the leading causes of 
morbidity and mortality that our country is suffering from now, recent data 
suggests that the overall reported cases of stroke in our country exceed 1 lakh 
per year. Hence it is very important that we understand the risk factors that are 
associated with stroke. The known risk factors of stroke are age, gender, 
diabetes mellitus, hypertension, elevated BMI. Hence there are modifiable and 
un-modifiable risk factors for stroke. Hence lifestyle changes are of core 
importance in management of stroke. A study done by Safarzadegan showed 
there was no significant correlation between lifestyle modification and 
metabolic syndrome. 
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   Hence this study not only aims to correlate the severity of 
stroke in patients with metabolic syndrome, but also the morbidity it ensues 
after a period of 60 days by the scaling system that are available to us. 
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REVIEW OF LITERATURE 
As stroke is one of the most leading causes of  mortality and morbidity in our 
country ,there is a need to assess the risk factors, management and efficacy of 
treatment not only at the scale of the patient but also with respect to the clinical 
trials that we can do. Hence in this respect it is of great importance that for 
patients who are recovering from stroke there are more important end points 
rather than death and the recurrence of stroke. And since stroke is a long term 
morbid condition we have to take into account the functional well-being of the 
patients as well. And it is for this purpose that the NATIONAL INSTITUTE OF 
STROKE SCALE (NIHSS), THE MODIFIED RANKIN (mRS) and the 
BARTHEL INDEX was developed. As with all scales these scales also have 
their limitations and their strengths of which we shall discuss in great detail 
later. And as mentioned earlier it is not only the severity of stroke that has to be 
looked into but also the functional impairment that the patient suffer from for 
example a patient who has a lower score in a NIHSS score scale might have a 
higher score in his quality of life measures. Hence it is important that we look 
into both these scaling systems for stroke.  In this study we would be using the 
NIHSS scale and the MRS scale to assess the severity of stroke at presentation 
and the morbidity faced by these patients after a period of 60 days and to assess 
if metabolic syndrome in itself is a reversible factor which can be modified. 
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  National Institute of Health Stroke Scale 
As to all scaling system NIHSS scale has its strengths and its limitations. It 
incorporates a 15 item scale which is part of the basic neurological examination, 
where it pays specific attention to those aspects that are more affected by stroke. 
The 15 item scale examines ones language, speech, motor function, 
consciousness, eye movements, cerebellar function, neglect, visual fields, 
neglect and so forth. The scoring system of NIHSS scale is from 0-42, with 0 
being no stroke and 42 being very severe stroke. A score greater than 21 in itself 
is considered as severe stroke. To assess level of consciousness there is a 
standard approach on scaling these patients who are not able to respond to oral 
commands. 
    The history of NIHSS scale starts as far as 1980 where 
it was used as a consistent tool for research purposes for reporting neurological 
deficits in patients with acute stroke. This was used in trials of intervention in 
stroke as in case of thrombolysis and in case where neuroprotective agents were 
used. The scale was derived from previous scales that were existent in Canada 
and other parts of Europe. And at present it is one of the most widely used 
scaling system in acute stroke in clinical trials as well as in management of 
cases in wards. 
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    On the basis of this a modified NIHSS scale was made 
with the purpose that it would be much faster to perform, and it has an 11 point 
scoring system. But since NIHSS in itself took only 6 minutes to complete the 
importance of the mNIHSS has reduced and is not in use even in trials and in 
management of cases in ward. 
Coming to the advantages of this widely used scoring system is that  
1. It is easy to perform. 
2. It’s not time consuming, taking about 6 min to perform the whole test. 
3. There are no instruments that are required. 
4. It has been proven with various clinical studies of its efficacy. 
5. It helps to assess the clinical improvement or deterioration of the patient, a 
change of score even by 2 is significant. 
6. There are no major changes even when it’s used by trained non-medical 
personal. 
7. It can even be used by non-neurologist. 
8. Its validity even holds when used via telemedicine. 
9. There are training apps even online, DVD, and mobile phones which can be 
used to high degree of accuracy. 
6 
 
10. There is clinical correlation that is obtained with NIHSS and the ones 
obtained by imaging in the form of CT brain or MRI brain. 
11. It has great predictive ability in not only assessing acute stroke but also the 
hospital stays and the morbidity of patients over a period of 90 days. 
12. With respect to the other scaling system like the mRS and the BI, this 
system has greater sensitivity and specificity even when the sample size is 
small. 
 
LIMITATIONS OF NIHSS SCALE 
1. It is more biased to the dominant hemisphere, with non-dominant 
hemisphere validity being less. 
2. A lower core in NIHSS does not mean the patient has less disability as 
discussed before. A score of 1 in NIHSS means the patient as mild stroke, 
but this might be a visual field defect which hampers his quality of life to 
a great extent. 
3. Posterior territory stroke has less validity with respect to other stroke 
like anterior circulatory stroke. 
4. NIHSS scale gives less importance to cranial nerve examination. 
5. With respect to quantifying the volume of infarct size, it is noted that 
for the same score the right sided non dominant stroke has greater volume 
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with respect to the left sided dominant stroke. Indirectly implying the fact 
that, there is a bias for this scale towards the dominant hemisphere. 
 
6. The quality of life index and the NIHSS scale does not correlate in 
certain instances as described earlier. Hence a low score in the NIHSS 
scale does not mean that the functional disability is less which is amply 
clear from the example before. 
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MODIFIED RANKIN SCALE 
The Rankin scale is named after the Scottish physician John Rankin, who made 
the scale in in view to assess the disability of the patient with specific reference 
to the mobility of the patient. Initially this scale was made to assess the patients 
who suffered from stroke to assess the global disability of these patients which 
was later modified to be used in clinical trials and hence the name modified 
Rankin scale. 
The modified Rankin scale was used initially in a study in Great Britain for 
patients suffering from transient ischemic attack. After this the scale has gained 
popularity and now is widely used to assess the functional outcome of patients 
who suffer from stroke. There are various variations of the mRS scale but are 
not used in clinical purpose or for trials. As in the case of NIHSS scale the mRS 
scale has its strengths and its limitations some of them are as follows. 
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STRENGTHS OF mRS SCALE 
1. It is easy to perform 
2. It takes about 5 min to perform 
3. It is in close correlation with other stroke scales like the NIHSS scale and the 
BI. 
4. The volume of infarct correlates well with the imaging findings of patients 
with stroke. 
5. It has a 6 point score which correlates well with the outcome of patients. 
6. As in the case of NIHSS scale there are various mobile phone apps, DVD ,  
online certificate courses for learning  this scale. 
LIMITATIONS OF THE mRS SCALE 
1. Since there are only 6 point score it is less probable to change than other 
stroke scales. 
2. The specificity of the scale is less. 
3. Inter observer variability is high with respect to this scale. 
4. Detailed training in scripted interviews is required to improve the reliability 
and the consistency of this scale. 
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    There are various modifications for the mRS scale of 
noteworthy to mention is the use of proxies to assess the patients and to assess 
prestroke score for mRS.  
1. Since these patients have various disabilities in the form of comprehension, 
aphasias, it is valuable that an informant who is close to the patient completes 
the scale. And these are proxies that are used to complete the scaling system. 
But the reliability of these scoring systems is less than those in which there are 
no proxies. 
2. The use of prestroke modified Rankin score is used mainly in clinical trials as 
an exclusion criteria when the prestroke is greater than 2. And this has moderate 
reliability and validity. 
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BARTHEL INDEX 
The history of the Barthel index starts as early as the 1960s, and was developed 
for a simple index to assess the improvement in patients in rehabilitation and 
how independent they are in their day to day activities and to plan discharges in 
patients with stroke admitted in rehabilitation centres. The scale was pioneered 
by Mahoney and Dorothea Barthel. In the following years the scale has been 
accepted as a good scale even for assessing the geriatric population. The BI is 
the most commonly used scale to assess functional improvement in the 
rehabilitation setting and the second most used index in patients suffering from 
acute stroke to assess their functional disability after the mRS scale. The scale 
uses mainly activities of daily living and uses a 10 tasks, and the tasks are 
graded to a score of zero to hundred. This scale tests the independence of the 
patient suffering from stroke during the acute phase and also during the 
rehabilitation phase of these patients. The higher the score in the BI it indicates 
the patient is recovering and has greater independence to his activities of daily 
living. So a patient with a score of 50 is less independent when compared to a 
patient with a score of 80, and a score of greater than 80 is taken as one who can 
be discharged and sent home as he can manage his activities of daily living. 
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STRENGTHS OF THE BARTHEL INDEX 
1. It is well validated. 
2. Good prognostic tool. 
3. Predicts recovery of patients. 
4. Duration of rehabilitation required. 
5. Co relates well with other indexes mentioned earlier. 
6. Inter observer variability is good in this scale. 
LIMITATIONS OF THE BARTHEL INDEX 
1. The cognitive impairment’s and impairments due to speech are not 
calculated. 
2. Stroke mortality is not well represented. 
3. The floor and ceiling effect of the BI, indicates that a patient with severe 
morbidity following discharge may be high on a scale, and a patient who has 
improved significantly in the ICU setting will still score low and hence the 
response to the clinical change in patients is low, it is due to this fact that the BI 
is more widely used in the rehabilitation centre than in intensive care 
management. 
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    The BI is one of the earliest scales made to assess the 
independence of patients following which emerged much more complex indices 
to assess the activity of daily living, of noteworthy to mention are E-ADL, 
Lawton I-ADL, Nottingham Extended ADL and so forth. The strengths of these 
scales are the fact that the limitation of the BI is taken into account and adjusted 
to as in the case of the ceiling effects as described earlier. 
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METABOLIC SYNDROME 
As described earlier metabolic syndrome is one that can be modified based on 
life style modification, and in recent times is one of the most important public 
health hazard in view of the lifestyle that is prevalent in our modern cities the 
excess calorie intake the sedentary life style that is prevalent not only among the 
aged but also the youth of our community. And with the exploding population it 
is one which should be dealt with swiftly and aggressively. Metabolic syndrome 
is associated with major health hazards our community faces such as 
1. Metabolic syndrome itself increases the risk of type 2 diabetes by 4 fold. 
2. Metabolic syndrome increases the risk of coronary artery disease by 3 
fold. 
3. Metabolic syndrome increases the risk of heart attacks by 3 fold. 
4. Metabolic syndrome increases the risk of stroke by 4 fold. 
                         Metabolic syndrome is in itself a risk factor for atherosclerosis 
and its complication and hence it should be investigated for as it directly 
correlates with the long term mortality and morbidity for patients suffering from 
this. 
                                 The history of metabolic syndrome started in the early parts 
of the 19 century when a physician demonstrated diabetes, hypertension and 
gout in the same patient. It was nearly 20 years hence that it was noticed that 
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patients who suffer from diabetes and cardiovascular disease also had increased 
abdominal circumference due to adipose deposition. And 20 years following 
this hypertension was also added into the mix in a conference in Europe for 
diabetes which comprised of diabetes, hypertension, and obesity. It was not 
until late 1980 when a scientist by the name of Raven introduced the concept of 
insulin resistance and it is he who named it as SYNDROME X. Later on in the 
1990’s it was renamed as a insulin resistance syndrome. Following its clinical 
implication various diagnostic criteria’s have come into being .Some of them 
are 
1. The WHO criteria  
2. The EGIR criteria 
3. NCEP ATP 11 
4. AACE criteria 
5. IDF criteria. 
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PREVALENCE OF METABOLIC SYNDROME 
  The prevalence of metabolic syndrome is estimated to be one in every 4 
as estimated by the international diabetes federation. There are genetic 
and non-genetic factors that are responsible for the prevalence of 
metabolic syndrome. Some of the associations of metabolic syndrome are 
genetic, smoking, alcohol consumptions, family history, sedentary 
lifestyle, obesity and so forth. There are multiple studies that correlate 
with the development of metabolic syndrome in patients with the above 
associations such as Framingham’s study, parks study, IDF.  
 
PATHOLOGY OF METABOLIC SYNDROME 
Metabolic syndrome pathology is multifactorial ranging from insulin 
resistance, genetic causes, hypertension, chronic stress, and low grade of 
underlying inflammation .It is the interplay with these factors that are the 
factors responsible for the development of metabolic syndrome. A 
graphical representation of the same is given below. 
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The various components of  Metabolic syndrome are  
1. Abdominal obesity 
2. Insulin resistance 
3. Dyslipidemia 
4. Hypertension 
ABDOMINAL OBEISITY 
An increase in the prevalence of abdominal girth is markedly due to the 
life style changes that we as a human race have come across, with more 
prevalence in the western world and in urban areas than the rural 
indirectly indicating that it may be due to sedentary life style, cheap high 
calorie intake of food items. It is an epidemic in its own way. The excess 
calorie that is present in the body gets converted to adipose tissue which 
is constellation of cells like the adipocytes, immune mediated cells, blood 
vessels, and with further nutrient excess there is both hypertrophy of each 
adipocytes and hyperplasia of the cells as well. It is this adipocytes that 
serve as a medium for production of inflammatory mediators when it 
comes in contact with stimulants like hypoxia .It is this low level of 
inflammation that is the cause of increased atherosclerosis and its varied 
complication. There are various waist circumference cut off depending on 
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the ethnicity and some of them have been listed 
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INSULIN RESISTANCE 
Insulin resistance is described as the condition in which normal amount of 
insulin concentration does not produce the response it is supposed to, due to this 
the beta cells of pancreas produce more amount of insulin because of the 
persistent hyperglycemia. This hyper insulinemia compensates for the 
hyperglycemia and makes the person normoglycemic. But due to this resistance 
there is an overexpression of the insulin receptors. Due to this there are some 
actions insulin that are accentuated and some that are not due to the insulin 
resistance, it is this mixture of over activity and under activity that is the cause 
of metabolic syndrome in a patient with insulin resistance. 
In due time the pancreas cannot produce extra insulin needed due to the insulin 
resistance and a burn out of the pancreatic islets happen ,during this phase leads 
to sever hyperglycemia and overt diabetes. Although an increased waist 
circumference is the norm for insulin resistance it can also be seen in patients 
with normal waist circumference with abnormal adipose distribution. But 
classically it is the upper body adipose deposition that strongly correlates with 
the development of metabolic syndrome. 
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DYLIPIDEMIA 
Dyslipidemia is a condition characterised by the elevation of lipids in our body. 
There is elevation of plasma cholesterol, triglycerides, and lipoproteins with 
reduced HDL and elevated LDL. The most common to elevate is the cholesterol 
level. There are various causes for dyslipidemia some of them are diabetes , 
PCOD , Cushing’s syndrome , hypothyroidism and so on. 
The pathogenesis behind dyslipidemia in a patient with insulin resistance are 
multiple. 
1. Insulin functions normally to supress lipid metabolism and hence in a 
condition where there is sufficient insulin resistance this is inhibited 
causing lipolysis and the release of these free fatty acid into circulation 
thereby causing dyslipidemia 
 
2. Insulin normally functions in the degradation of apo protein B via PI3K 
pathway, and hence insulin resistance produces increased level of very 
low density lipoprotein . 
 
3. Insulin also regulates other enzymes which metabolises VLDL like the 
lipo-protein lipase. This enzyme is the rate limiting enzyme in the 
metabolism of VLDL. Hence insulin not only acts via the PI3K pathway 
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it also acts via the LPL pathway in its metabolism whereby increasing its 
concentration in serum.  
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HYPERTENSION 
Hypertension is the term used to describe elevated blood pressure. The causes 
of hypertension can be varied from primary cause or secondary causes. Some of 
the causes of secondary hypertension include OSAS, CKD, Reno vascular 
hypertension, endocrine causes of hypertension like hyperthyroidism, 
pheochromocytoma, diabetes, Cushing’s syndrome. 
While essential hypertension can be genetic it is often associated with metabolic 
syndrome. The pathology behind metabolic syndrome producing hypertension 
is the fact that hyperinsulinemia, hyperglycemia activate the renin angiotensin 
aldosterone system, which in turn results in hypertension via 
1. Increased angiotensin level 
2. Kidney reabsorbs more amount of sodium 
3. Increased cardiac output. 
4. Adipose tissue is postulated to produce aldosterone in the presence of 
increased angiotensin levels. 
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Management of hypertension based on JNC 8 is as follows. 
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Diagnosis of metabolic syndrome 
Over a period of time there has been a strive to define and diagnose metabolic 
syndrome. Following which there has been different criteria for the diagnosis of 
metabolic syndrome brought about by various organisations like the IDF, 
NCEP, WHO, AACE. For the purpose of this study the IDF guidelines are 
followed. The criteria’s are as follows: 
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TREATMENT OF METABOLIC SYNDROME 
 
The treatment of metabolic syndrome winds around the concept of making 
lifestyle modifications.  
1. Exercise: Exercise is one of the most important life style modifications to be 
made. It helps to reduce weight, lower blood pressure, and increase peripheral 
absorption of glucose, glycemic control, reduces dyslipidemia, and improves 
insulin resistance. 
 
2. Healthy diet: In this new age of ours eating healthy is an important corner 
stone in the management of metabolic syndrome. It helps in reducing weight, 
improve cholesterol levels, improve insulin resistance, reduce the risk of 
cardiovascular disease, stroke. 
 
3.  Weight reduction: It is a by-product of exercise and healthy diet. Weight loss 
as a single entity reduces all aspects of metabolic syndrome 
4. Alcohol abstinence and cessation of smoking: 
5. Pharmacological treatment: medication revolves around control of diabetes 
with OHA or insulin, antihypertensive, statins for dsylipidemia. It is important 
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to note that medication along with life style modification provides the greatest 
benefit in the management of metabolic syndrome. 
  
 
 
  
34 
 
AIMS AND OBJECTIVES 
 
Primary Objective 
1. To examine the association of the metabolic syndrome and its components on 
acute ischemic stroke. 
Secondary Objective(s) 
1. To find the association of metabolic syndrome and the severity of 
ischemic stroke. 
2. To evaluate the effects of Metabolic Syndrome and its components on the 
short-term (60day) prognosis of patients with acute ischemic stroke. 
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MATERIALS AND METHODS: 
    In the following Hospital based study for the A Study to find the association 
of Metabolic Syndrome and its components in Ischemic Stroke 100 patients 
who were in-patient at the department of Medicine were evaluated for metabolic 
syndrome and its severity of which 50 were cases and 50 were controls.   
 Period of study: april2016 to september2016 
Study design: case control study. 
Study conducted: Madras medical college hospital, Chennai.  
Sample size   : 100 subjects. 50 were cases and 50 were control.  
 
 
INCLUSION CRITERIA:  
1. All the subjects presented clinical characteristics of acute ischemic stroke 
WITHIN 7 DAYS OF ONSET, confirmed by cranial computed tomography 
and/or magnetic resonance imaging/angiography. 
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EXCLUSION CRITERIA:  
1. Criteria for exclusions were patients who experienced the onset of stroke 
more than 7 days before hospitalization. 
 
2. Patients with cerebral haemorrhage, subarachnoid haemorrhage, brain 
tumor or other central nervous system disorders were also excluded. 
 
     3. Those not willing to give consent were also excluded.  
IDF Criteria for metabolic syndrome  
1. Central or abdominal obesity (measured by waist    circumference :)in 
men > 102cms  and in women >88 cms    
2. Triglycerides > or equal to 150 mg/dl or using cholesterol medication/ 
3. HDL Cholesterol: men < 40 mg/dl, women <50 mg/dl or using 
cholesterol medication. 
4. Blood pressure > or equal to 130/ 85 mmHg or on anti-hypertensive 
5. Fasting glucose > or equal to 100 mg/dl or on anti-diabetic drugs 
The presence of any three of the following five risk components. 
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Data collection and Methods 
Data collection was performed by using a standardized questionnaire 
based on an extensive manual and follow up information. 
• Patients were classified into two groups at baseline based on whether or 
not the diagnostic criteria for MetS were met. 
• Data collection was performed by using a standardized questionnaire 
based on an extensive manual and follow-up information. 
• Initial severity of stroke in cases will be measured by the NIHSS scale. 
Level of stroke severity is measured as 0(no stroke) ; 1-4 (minor stroke) ; 
5-15 (moderate stroke ) ; 15-20 ( moderate to severe stroke ) and 21-42 
(severe stroke).  
• The patients would be followed up and stroke severity assessed at 1st 
week and 1 month post stroke. The functional outcome is measured by 
modified Rankin scale 60 days post stroke. Patients who died scored 6 in 
the mRS. and mRS =3 were used as cut-off scores to defined poor 
outcome.  
• Patients will be followed up with hospital visits during the first and 6 
months after the stroke event. Patients who were unable to attend the 
scheduled visits or had migrated from the city will be contacted by 
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telephone. In case of death, dates and causes were registered by gathering 
information from relatives. 
Product / Procedure / Investigation Details 
1. Fasting plasma glucose 
2. Fasting lipid profile 
3. BP record 
4. Anthropometric tests ( height, weight, BMI , waist circumference) 
5.  CT brain/MRI brain 
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RESULTS 
This study group included total number of 100 subjects ,among these 50 were 
cases and 50 control. 
 
ANALYSIS OF CASE AND CONTROL WITH RESPECT TO AGE. 
 
 Age group Total 
40-50 51-60 61-70 71-80 
group 
case 
Count 1 17 23 9 50 
% within 
group 
2.0% 34.0% 46.0% 18.0% 100.0% 
control 
Count 6 14 24 6 50 
% within 
group 
12.0% 28.0% 48.0% 12.0% 100.0% 
Total 
Count 7 31 47 15 100 
% within 
group 
7.0% 31.0% 47.0% 15.0% 100.0% 
Pearson Chi-Square=4.483 p= 0.214 
 
  
40 
 
 
 
 
The age of the study population ranged from 40 onwards to 80, With the peak 
incidence of stroke from the age group of 60-70.The study showed a p value of 
0.214, and hence the study was independent of age. 
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ANALYSIS OF CASE AND CONTROL WITH RESPECT TO SEX. 
 
 SEX Total 
Male Female 
group 
case 
Count 25 25 50 
% within group 50.0% 50.0% 100.0% 
control 
Count 25 25 50 
% within group 50.0% 50.0% 100.0% 
Total 
Count 50 50 100 
% within group 50.0% 50.0% 100.0% 
Pearson Chi-Square=0 p=1 
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Both case and control had equal proportion of male and female in the study. 
And the study had a p value of 1, indicating that there was no significant 
difference in the sex in the study with respect to the case and control. 
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ANALYSIS OF CASE AND CONTROL WITH RESPECT TO NIHSS 
SCORE. 
 
 NIHSS class Total 
Minor Moderate Moderate 
to severe 
Severe 
group 
case 
Count 3 6 15 26 50 
% within group 6.0% 12.0% 30.0% 52.0% 100.0% 
Control 
 Count 13 13 11 13 50 
% within group 26.0% 26.0% 22.0% 26.0% 100.0% 
 Total 
Count 16 19 26 39 100 
% within group 16.0% 19.0% 26.0% 39.0% 100.0% 
Pearson Chi-Square=13778 *p= 0.003 
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Analysis of NIHSS scale with respect to the case and control revealed more 
than 50% of cases to be severe while control was evenly distributed between the 
various severity of the NIHSS scale. The analysis revealed a statistically 
significant relation between cases and control with respect to the NIHSS scale. 
Thereby confirming a significant relation between the severity of ischemic 
stroke and metabolic syndrome. 
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ANALYSIS OF CASE AND CONTROL WITH RESPECT TO ALCOHOL 
INTAKE. 
Crosstab 
 Alcohol intake Total 
no yes 
group 
case 
Count 29 21 50 
% within group 58.0% 42.0% 100.0% 
control 
Count 30 20 50 
% within group 60.0% 40.0% 100.0% 
Total 
Count 59 41 100 
% within group 59.0% 41.0% 100.0% 
Pearson Chi-Square=0.041  p= 0.839 
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Analysis of the alcohol intake with the incidence of stroke within case and 
control did not yield a statistically significant relation between them. 
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ANALYSIS OF CASE AND CONTROL WITH RESPECT TO 
HYPERTENSION. 
 
 HYPERTENSIVE Total 
NO YES 
group 
case 
Count 0 50 50 
% within 
group 
0.0% 100.0% 100.0% 
control 
Count 40 10 50 
% within 
group 
80.0% 20.0% 100.0% 
Total 
Count 40 60 100 
% within 
group 
40.0% 60.0% 100.0% 
Pearson Chi-Square=66.667*  p<0.001 significant 
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Analysis of the data for the incidence of stroke in case and control with respect 
to hypertension revealed that there was a statistically significant relation 
between them. 
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ANALYSIS OF CASE AND CONTROL WITH RESPECT TO DIABETES 
MELLITUS. 
 DM Total 
NORMAL ABNORMAL 
group 
case 
Count 0 50 50 
% within 
group 
0.0% 100.0% 100.0% 
control 
Count 50 0 50 
% within 
group 
100.0% 0.0% 100.0% 
Total 
Count 50 50 100 
% within 
group 
50.0% 50.0% 100.0% 
Pearson Chi-Square=100.00*  p<0.001 significant 
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Analysis of the data for the incidence of stroke in case and control with respect 
to diabetes mellitus revealed that there was a statistically significant relation 
between them. 
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ANALYSIS OF CASE AND CONTROL WITH RESPECT TO TAG. 
 
 TAG Total 
NORMAL ABNORMAL 
group 
Case 
 
Count 13 37 50 
% within 
group 
26.0% 74.0% 100.0% 
Total 
Count 13 37 50 
% within 
group 
26.0% 74.0% 100.0% 
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ANALYSIS OF CASE AND CONTROL WITH RESPECT TO HDL. 
 
 HDL Total 
NORMAL ABNORMAL 
group 
case 
Count 28 22 50 
% within 
group 
56.0% 44.0% 100.0% 
control 
Count 43 7 50 
% within 
group 
86.0% 14.0% 100.0% 
Total 
Count 71 29 100 
% within 
group 
71.0% 29.0% 100.0% 
Pearson Chi-Square=10.928*  p<0.001 significant 
 
  
53 
 
 
Analysis of the data for the incidence of stroke in case and control with respect 
to HDL revealed that there was a statistically significant relation between them. 
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ANALYSIS OF CASE AND CONTROL WITH RESPECT TO 
ABDOMINAL CICUMFERENCE 
 ABD CIRCUMFERENCE Total 
NORMAL ABNORMAL 
group 
case 
Count 21 29 50 
% within 
group 
42.0% 58.0% 100.0% 
control 
Count 19 31 50 
% within 
group 
38.0% 62.0% 100.0% 
Total 
Count 40 60 100 
% within 
group 
40.0% 60.0% 100.0% 
Pearson Chi-Square=0.167   p=0.683 
Analysis of the abdominal circumference with the incidence of stroke within 
case and control did not yield a statistically significant relation between them. 
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ANALYSIS OF CASE AND CONTROL WITH RESPECT TO PACK 
YEARS. 
 PACK YEARS Total 
0-10 10-30 
group 
case 
Count 3 18 21 
% within group 14.3% 85.7% 100.0% 
control 
Count 6 17 23 
% within group 26.1% 73.9% 100.0% 
Total 
Count 9 35 44 
% within group 20.5% 79.5% 100.0% 
Pearson Chi-Square=0.940  p= 0.332 
 
Analysis of pack years with the incidence of stroke within case and control did 
not yield a statistically significant relation between them. 
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ANALYSIS OF CASE AND CONTROL WITH RESPECT TO mRS SCALE 
 MRS scale Total 
Less than 
3 
3-5 (Poor 
outcome 
Died 
group 
case 
Count 6 30 10 46 
% within 
group 
13.0% 65.2% 21.7% 100.0% 
control 
Count 18 19 8 45 
% within 
group 
40.0% 42.2% 17.8% 100.0% 
Total 
Count 24 49 18 91 
% within 
group 
26.4% 53.8% 19.8% 100.0% 
Pearson Chi-Square=8.682*   p= 0.013 
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The study showed significant correlation between the mRS scale and the 
severity of stroke after a period of 60 days in patients with metabolic syndrome. 
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CORRELATION BETWEEN mRS SCALE AND AGE 
 mRS scale Total 
less than 
3 
3-5 (poor 
outcome 
died 
Age group 
40-50 
Count 2 4 1 7 
% within  
age group 
28.6% 57.1% 14.3% 100.0% 
51-60 
Count 6 18 3 27 
% within  
age group 
22.2% 66.7% 11.1% 100.0% 
61-70 
Count 15 22 7 44 
% within 
 age group 
34.1% 50.0% 15.9% 100.0% 
71-80 
Count 1 5 7 13 
% within  
age group 
7.7% 38.5% 53.8% 100.0% 
Total 
Count 24 49 18 91 
% within 
 age group 
26.4% 53.8% 19.8% 100.0% 
Pearson Chi-Square=13.527 *   p= 0.035 
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 The study showed statistical significance between mRS scale and the age of the 
patients within the case and he control group. Indicating that age is a risk factor 
in patients with metabolic syndrome for severity of stroke. 
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CORRELATION BETWEEN NIHSS SCALE AND mRS SCALE 
 MRS scale Total 
less 
than 3 
3-5 (poor 
outcome 
Died 
NIHSS 
SCALE 
Minor 
Count 3 8 5 16 
% within 
 NIHSS scale 
18.8% 50.0% 31.2% 100.0% 
Moderate 
Count 8 11 0 19 
% within  
NIHSS scale 
42.1% 57.9% 0.0% 100.0% 
Moderate to 
severe 
Count 10 12 4 26 
% within 
 NIHSS scale 
38.5% 46.2% 15.4% 100.0% 
Severe 
Count 3 18 9 30 
% within  
NIHSS scale 
10.0% 60.0% 30.0% 100.0% 
Total 
Count 24 49 18 91 
% within  
NIHSS scale 
26.4% 53.8% 19.8% 100.0% 
Pearson Chi-Square=13.884*   p= 0.03 
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Correlations 
 NIHSS  
MRS 
 Correlation .302
****
  
Sig. (2-tailed) P<0.01  
N 100  
**. Correlation is significant at the 0.01 level (2-tailed). 
 
The above analysis correlates between the NIHSS scale and the mRS scale and 
it shows a statistically significant relation between them, indicating that a high 
score in the NIHSS scale correlates with a high score in the mRS scale. 
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CORRELATION BETWEEN mRS SCALE AND ALCOHOL INTAKE. 
 MRS scale Total 
less than 
3 
3-5 (poor 
outcome 
died 
Alcohol 
intake 
no 
Count 19 24 9 52 
% within 
 alcohol intake 
36.5% 46.2% 17.3% 100.0% 
yes 
Count 5 25 9 39 
% within  
alcohol intake 
12.8% 64.1% 23.1% 100.0% 
Total 
Count 24 49 18 91 
% within 
 alcohol intake 
26.4% 53.8% 19.8% 100.0% 
Pearson Chi-Square=6.462*   p= 0.040 
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 The study shows significant correlation with 
respect to alcohol intake in patients with metabolic syndrome with respect to 
their functional disability as seen by their higher mRS score. 
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CORRELATION BETWEEN HYPERTENSION AND mRS SCALE 
 mRS SCALE Total 
less than 3 3-5 (poor 
outcome 
died 
 
NORMAL 
BP 
Count 15 14 6 35 
% within   42.9% 40.0% 17.1% 100.0% 
HYPERTE-
NSIVE 
Count 9 35 12 56 
% within  16.1% 62.5% 21.4% 100.0% 
Total 
Count 24 49 18 91 
% within 
BP 
26.4% 53.8% 19.8% 100.0% 
Pearson Chi-Square=8.084*   p= 0.018 
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The study showed significant statistical correlation with respect to 
hypertensive’s and the severity of stroke which was evident by the higher mRS 
score for this sub group of patients. 
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CORRELATION BETWEEN DIABETICS AND mRS SCALE 
 MRS grade Total 
less than 3 3-5 (poor 
outcome 
died 
 
Non 
diabetic 
Count 18 19 8 45 
% within  40.0% 42.2% 17.8% 100.0% 
Diabetics 
Count 6 30 10 46 
% within  13.0% 65.2% 21.7% 100.0% 
Total 
Count 24 49 18 91 
% within 
DM 
26.4% 53.8% 19.8% 100.0% 
Pearson Chi-Square=8.682*   p= 0.013 
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The study showed significant correlation in the subgroup of patients with 
diabetes mellitus with respect to the severity of stroke as evident by the higher 
mRS score. 
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CORRELATION BETWEEN TAG AND mRS SCALE 
 mRS SCALE Total 
less than 
3 
3-5 (poor 
outcome 
died 
 
NORMAL TAG 
Count 3 5 3 11 
% within 27.3% 45.5% 27.3% 100.0% 
ABNORMAL 
TAG 
Count 3 25 7 35 
% within  8.6% 71.4% 20.0% 100.0% 
Total 
Count 6 30 10 46 
% within 
TAG 
13.0% 65.2% 21.7% 100.0% 
Pearson Chi-Square=3.314   p= 0.191 
 
The study did not show any statistical correlation between the severity of stroke 
based on the mRS score and the level of TAG in patients. 
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     CORRELATION BETWEEN HDL LEVELS AND mRS SCALE 
 MRS SCALE Total 
less than 
3 
3-5 (poor 
outcome 
died 
 
NORMAL 
HDL 
Count 20 32 13 65 
% within  30.8% 49.2% 20.0% 100.0% 
ABNORMAL 
HDL 
Count 4 17 5 26 
% within  15.4% 65.4% 19.2% 100.0% 
Total 
Count 24 49 18 91 
% within 
HDL 
26.4% 53.8% 19.8% 100.0% 
Pearson Chi-Square=2.572   p= 0.276  
 
The study did not show any significant correlation with respect to the severity 
of stroke and the HDL level of patients
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CORRELATION BETWEEN PACK YEARS AND mRS SCALE 
 mRS SCALE Total 
less than 3 3-5 (poor 
outcome 
died 
 
0-10 
Count 4 5 0 9 
% within 
PACK 
YEARS 
44.4% 55.6% 0.0% 100.0% 
10-30 
Count 2 21 10 33 
% within 
PACK 
YEARS 
6.1% 63.6% 30.3% 100.0% 
Total 
Count 6 26 10 42 
% within 
PACK 
14.3% 61.9% 23.8% 100.0% 
Pearson Chi-Square=10.095*   p= 0.006 
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The study showed significant correlation with respect the  pack years the patient 
smoked and the severity of stroke for this subgroup as evident by the higher 
mRS scale for these patients. 
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Group Statistics 
 group N Mean Std. Deviation Std. Error Mean 
MRS 
case 50 3.5000 1.87628 .26535 
control 50 2.6800 1.97370 .27912 
t value= 2.129*P=0.036 
 
 
When the mean mRS scale was done for the subgroup of patients with 
metabolic syndrome and those without metabolic syndrome, that is the case and 
control it is evident that those with metabolic syndrome had mean mRS score 
higher than the control group with a p value of 0.036 indicating its statistical 
significance. 
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DISCUSSION 
The study was conducted with a sample size of 100 patients ,with an intention 
to correlate the severity as well as the 60 day functional morbidity in patients 
who suffered from ischemic stroke by using scaling system such as the NIHSS 
and the mRS scale 
  The study divided the patients into a set of control and cases with 
50 patients in each set. The findings of the study are as such. 
  The significance of age, sex, was not evident between patients with 
and without Metabolic Syndrome. While systemic hypertension, diabetes 
mellitus, and HDL levels showed statistical significant correlation with respect 
to the development of stroke. Implying that the components of Metabolic 
syndrome that is, diabetes, hypertension, HDL levels do correlate with the 
incidence of stroke. With the chi –square values of the same being 
66.67,100,10.92 respectively. 
  The NIHSS scale when compared with both the population , that is 
those with metabolic syndrome and those without metabolic syndrome, we get a 
statistical significant data ,in which a large subset of the population presents 
with severe stroke ,which is measured by a score greater than 21 in the NIHSS 
scale. 83 % of cases had moderate to severe stroke when compared with control 
which had only 26 %. 
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  When modified rankin scale was used to identify the functional 
disability after a period of 60 days which yielded a significant correlation. 
When different subsets were used in relation to the mRS scale it was well 
evident that age, sex, alcohol consumption, systemic hypertension, diabetes 
mellitus, pack years of cigarettes smoked showed significant correlation. 
Implying that these factors increased both the severity and the functional 
disability of patients. Age had a chi square value of 13.52,sex a value of 
6.617,alcohol consumption a value of 6.462, hypertensive a value of 8.084 and 
diabetics a value of 8.682. 
  One interesting analysis that was obtained was that although the 
amount of pack years did not show any correlation for the incidence of strokes 
in patients with and without metabolic syndrome. Once stroke had developed, 
those with a greater pack years, had a higher score in the mRS scale indicating 
that, the functional disability of smokers with stroke was far more than those 
without stroke. It should also be noted that the males had a significantly higher 
score when compared to females. This could be attributed to fact that there are 
confounding factors like smoking and alcohol abuse which are more prevalent 
in the former subgroup. 
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When mean of the mRS scale was calculated for both the control and the 
case group it was evident that patients with metabolic syndrome showed 
significant worse outcome than those without metabolic syndrome. 
 
LIMITATION OF THE STUDY 
1. The size of the sample is small 
2. The data collected was from a single centre 
3. Loss of cases to attrition was present 
4. mRS scale was obtained from relatives in patients with severe stroke. 
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CONCLUSION 
It was the findings of the study, that patients with metabolic syndrome have a 
more severe disease when it comes to the acute presentation of stroke and also 
after a period of 60 days were there was greater functional disability in patients 
with metabolic syndrome. 
  Patients who are smokers did not have any significant rise in 
incidence of stroke among those with metabolic syndrome and those without 
metabolic syndrome .There was a significant correlation with this functional 
disability ,that is those patients with metabolic syndrome had a worse mRS 
scale than those without metabolic syndrome. Indicating that metabolic 
syndrome affected the quality of life and suffering of patients were much 
greater than the control group. 
  Individual risk factors like age, smoking ,alcohol consumption 
significantly affected patients with metabolic syndrome, whereby the patients 
fared worse in the mRS scale ,hence as an individual risk factor patients with 
metabolic syndrome had a worse functional outcome if they were elderly 
smoker or an alcoholic . 
  The study thus concludes and affirms that Metabolic Syndrome is a 
risk factor for severity of stroke and an independent risk factor for severity of 
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stroke and an independent risk factor for functional disability. Other risk factors 
like alcoholism also increased the severity of stroke. 
  The limitation of the study was that the total sample size was 100 
cases and the data collected was from a single institution. Loss of patients to 
attrition and the fact that the mRS scale was obtained from relatives for patients 
with severe stroke are other short falls of the study.  
 
